Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Julius-Maximilians-Universitaet Wuerzburg has 3 pending office actions in the Biotechnology & Pharmaceuticals area. This number matches the count of 3 distinct examiners, while the matters are divided between 2 distinct art units. NICKOL, GARY B is the busiest examiner with 1 pending office action.
The use of 2 distinct art units suggests that the university's pharmaceutical research spans different specialized classifications. With 1 pending office action for the busiest examiner, the prosecution is spread across multiple points of review within the biotechnology sector at the patent office.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NICKOL, GARY B | 1 | 47.1% | +31.1% |
| PAGUIO FRISING, MICHELLE F | 1 | 71.1% | +39.3% |
| MAHLUM, JONATHAN DAVIS | 1 | 51.4% | +25.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18564921 | RECOMBINANT PROTEINACEOUS BINDING MOLECULES | NICKOL, GARY B | — |
| 18038393 | BIOCOMPATIBLE COMPOSITE MEMBRANE, METHOD FOR FABRICATING THE MEMBRANE, BIOREACTOR AND METHOD FOR INVESTIGATING CELLS ATTACHED TO THE BIOCOMPATIBLE COMPOSITE MEMBRANE | PAGUIO FRISING, MICHELLE F | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17906184 | PROTEOLYSIS TARGETING CHIMERA (PROTAC) FOR DEGRADATION OF AURORA A-KINASE | MAHLUM, JONATHAN DAVIS | 80d overdue |
| 18564921 | RECOMBINANT PROTEINACEOUS BINDING MOLECULES | NICKOL, GARY B | — |
| 18038393 | BIOCOMPATIBLE COMPOSITE MEMBRANE, METHOD FOR FABRICATING THE MEMBRANE, BIOREACTOR AND METHOD FOR INVESTIGATING CELLS ATTACHED TO THE BIOCOMPATIBLE COMPOSITE MEMBRANE | PAGUIO FRISING, MICHELLE F | — |
| Art Unit | Apps |
|---|---|
| 1651 | 1 |
| 1625 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18564921 | RECOMBINANT PROTEINACEOUS BINDING MOLECULES | NICKOL, GARY B | — | §101§102§112 | Non-Final OA | — | Pending | Nov 28, 2023 |
| 18038393 | BIOCOMPATIBLE COMPOSITE MEMBRANE, METHOD FOR FABRICATING THE MEMBRANE, BIOREACTOR AND METHOD FOR INVESTIGATING CELLS ATTACHED TO THE BIOCOMPATIBLE COMPOSITE MEMBRANE | PAGUIO FRISING, MICHELLE F | 1651 | §102§103§112 | Non-Final OA | — | Pending | May 23, 2023 |
| 17906184 | PROTEOLYSIS TARGETING CHIMERA (PROTAC) FOR DEGRADATION OF AURORA A-KINASE | MAHLUM, JONATHAN DAVIS | 1625 | §103 | Final Rejection | 80d overdue | Pending | Sep 12, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial